Crystal structures of FadD32 and pks13-ACP domain from Corynebacterium diphtheriae

Rong Chen1, Jingting Yuan1, Xiaoqian Shi1

  • 1State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, 300071, Tianjin, China.

Insights

Researchers elucidated the structures of key proteins involved in mycolic acid synthesis, a crucial factor in Mycobacterium and Corynebacterium virulence. These findings offer insights into novel anti-tuberculosis drug development.

Area of Science:

  • Microbiology
  • Structural Biology
  • Drug Discovery

Background:

  • Mycolic acids (MAs) are essential virulence factors in Mycobacterium and Corynebacterium species.
  • MA biosynthesis is a promising target for developing new anti-tuberculosis (TB) drugs.

Purpose of the Study:

  • To investigate the structures and functions of proteins in the MA biosynthesis pathway.
  • To provide structural insights into the assembly of FadD32 and polyketide synthase 13 (pks13).

Main Methods:

  • X-ray crystallography was used to determine the structures of FadD32 with substrates.
  • The holo-form of the ACP-domain from Corynebacterium diphtheriae was also crystallized.
  • In vitro biochemical assays were performed to analyze protein function.

Main Results:

  • Crystal structures of FadD32 bound to substrates were obtained.
  • The holo-form structure of the ACP-domain from C. diphtheriae was determined.
  • Structural and biochemical data revealed new insights into the assembly of FadD32 and pks13.

Conclusions:

  • The elucidated structures provide a foundation for understanding the MA biosynthesis mechanism.
  • These findings could guide the rational design of novel anti-TB agents targeting FadD32 and pks13.